We at BCC Research are excited to announce the launch of the long term forecasting model for lung cancer drug Tarceva®, and we are offering you a complimentary introductory sample of the product.
The BCC Research Tarceva® Forecast is a quantitative forecast model in an easily accessible Microsoft® Excel® spreadsheet, segmented by specific parameters.
Click here to download an introductory sample of the Tarceva® Forecast Model.
The model features:
Use the BCC Research Tarceva® Forecast to:
Questions? How can we help you? Contact us:
(+1) 781-489-7301, ext. 1
The BCC Research Tarceva® Forecast is a quantitative forecast model in an easily accessible Microsoft® Excel® spreadsheet, segmented by specific parameters.
Click here to download an introductory sample of the Tarceva® Forecast Model.
The model features:
- Market demand forecasts for Tarceva® annually for the years 2010 to 2030 by volume (number of patients) and value (in U.S. dollars)
- Segmentation of volume and value for the following regions: U.S., Japan, Europe, Latin America, China, Asia, Middle East
- Patient volumes, with forecasts by causal factors including population by age range, smoker data, and prevalence
Use the BCC Research Tarceva® Forecast to:
- Examine forecasted market demand for Tarceva®: competitor assessment; market opportunity assessment
- Identify new business and investment opportunities for products in the lung cancer segment
- Validate other Tarceva® market-demand data to which you have access
Questions? How can we help you? Contact us:
No comments:
Post a Comment